Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-21-136348
Filing Date
2021-11-09
Accepted
2021-11-09 17:05:59
Documents
6
Effectiveness Date
2021-11-09

Document Format Files

Seq Description Document Type Size
1 FORM S-3ASR tm2132014d1_s3asr.htm S-3ASR 208946
2 EXHIBIT 5.1 tm2132014d1_ex5-1.htm EX-5.1 11451
3 EXHIBIT 23.1 tm2132014d1_ex23-1.htm EX-23.1 2767
4 GRAPHIC tm2132014d1_ex5-1img002.jpg GRAPHIC 4508
5 GRAPHIC tm2132014d1_ex5-1img001.jpg GRAPHIC 3054
6 GRAPHIC image_001.jpg GRAPHIC 23338
  Complete submission text file 0001104659-21-136348.txt   267263
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-260924 | Film No.: 211393144
SIC: 2834 Pharmaceutical Preparations